UniProt ID | RBP10_HUMAN | |
---|---|---|
UniProt AC | Q6VN20 | |
Protein Name | Ran-binding protein 10 | |
Gene Name | RANBP10 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 620 | |
Subcellular Localization | Cytoplasm, cytosol . Nucleus . Predominantly cytoplasmic. | |
Protein Description | Acts as a guanine nucleotide exchange factor (GEF) for RAN GTPase (By similarity). May play an essential role in hemostasis and in maintaining microtubule dynamics with respect to both platelet shape and function (By similarity). May act as an adapter protein to couple membrane receptors to intracellular signaling pathways. Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but does not affect estrogen-induced transactivation. In contrast to RANBP9, does not interact with Sos and does not activate the Ras pathway.. | |
Protein Sequence | MAAATADPGAGNPQPGDSSGGGAGGGLPSPGEQELSRRLQRLYPAVNQQETPLPRSWSPKDKYNYIGLSQGNLRVHYKGHGKNHKDAASVRATHPIPAACGIYYFEVKIVSKGRDGYMGIGLSAQGVNMNRLPGWDKHSYGYHGDDGHSFCSSGTGQPYGPTFTTGDVIGCCVNLINGTCFYTKNGHSLGIAFTDLPANLYPTVGLQTPGEIVDANFGQQPFLFDIEDYMREWRAKVQGTVHCFPISARLGEWQAVLQNMVSSYLVHHGYCATATAFARMTETPIQEEQASIKNRQKIQKLVLEGRVGEAIETTQRFYPGLLEHNPNLLFMLKCRQFVEMVNGTDSEVRSLSSRSPKSQDSYPGSPSLSPRHGPSSSHMHNTGADSPSCSNGVASTKSKQNHSKYPAPSSSSSSSSSSSSSSPSSVNYSESNSTDSTKSQHHSSTSNQETSDSEMEMEAEHYPNGVLGSMSTRIVNGAYKHEDLQTDESSMDDRHPRRQLCGGNQAATERIILFGRELQALSEQLGREYGKNLAHTEMLQDAFSLLAYSDPWSCPVGQQLDPIQREPVCAALNSAILESQNLPKQPPLMLALGQASECLRLMARAGLGSCSFARVDDYLH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAATADPG ------CCCCCCCCC | 13.05 | 22814378 | |
18 | Phosphorylation | GNPQPGDSSGGGAGG CCCCCCCCCCCCCCC | 36.48 | 25002506 | |
19 | Phosphorylation | NPQPGDSSGGGAGGG CCCCCCCCCCCCCCC | 46.31 | 25850435 | |
29 | Phosphorylation | GAGGGLPSPGEQELS CCCCCCCCCCHHHHH | 51.05 | 28188228 | |
36 | Phosphorylation | SPGEQELSRRLQRLY CCCHHHHHHHHHHHH | 18.01 | 25850435 | |
58 | Phosphorylation | TPLPRSWSPKDKYNY CCCCCCCCCCCCCCE | 24.26 | 24719451 | |
60 | Ubiquitination | LPRSWSPKDKYNYIG CCCCCCCCCCCCEEE | 62.43 | - | |
60 | Ubiquitination | LPRSWSPKDKYNYIG CCCCCCCCCCCCEEE | 62.43 | - | |
62 | Ubiquitination | RSWSPKDKYNYIGLS CCCCCCCCCCEEEEC | 41.33 | - | |
62 | Ubiquitination | RSWSPKDKYNYIGLS CCCCCCCCCCEEEEC | 41.33 | - | |
63 | Phosphorylation | SWSPKDKYNYIGLSQ CCCCCCCCCEEEECC | 24.27 | 22617229 | |
65 | Phosphorylation | SPKDKYNYIGLSQGN CCCCCCCEEEECCCC | 8.02 | 29759185 | |
69 | Phosphorylation | KYNYIGLSQGNLRVH CCCEEEECCCCEEEE | 30.72 | 29759185 | |
85 | Ubiquitination | KGHGKNHKDAASVRA CCCCCCCCCCHHHCC | 59.46 | - | |
236 | Ubiquitination | YMREWRAKVQGTVHC HHHHHHHHHCCEEEE | 26.90 | - | |
237 | Ubiquitination | MREWRAKVQGTVHCF HHHHHHHHCCEEEEE | 6.56 | 21906983 | |
293 | Ubiquitination | QEEQASIKNRQKIQK HHHHHHHHCHHHHHH | 43.51 | 21906983 | |
293 | Acetylation | QEEQASIKNRQKIQK HHHHHHHHCHHHHHH | 43.51 | 23236377 | |
300 | Acetylation | KNRQKIQKLVLEGRV HCHHHHHHHHHCCCH | 44.00 | 25953088 | |
300 | Ubiquitination | KNRQKIQKLVLEGRV HCHHHHHHHHHCCCH | 44.00 | - | |
301 | Ubiquitination | NRQKIQKLVLEGRVG CHHHHHHHHHCCCHH | 2.81 | 21906983 | |
333 | Ubiquitination | PNLLFMLKCRQFVEM CCEEEEEEHHHHHHH | 18.64 | - | |
344 | Phosphorylation | FVEMVNGTDSEVRSL HHHHHCCCHHHHHHH | 31.02 | 28985074 | |
346 | Phosphorylation | EMVNGTDSEVRSLSS HHHCCCHHHHHHHHC | 37.52 | 28985074 | |
350 | Phosphorylation | GTDSEVRSLSSRSPK CCHHHHHHHHCCCCC | 37.47 | 23403867 | |
352 | Phosphorylation | DSEVRSLSSRSPKSQ HHHHHHHHCCCCCCC | 25.59 | 20363803 | |
353 | Phosphorylation | SEVRSLSSRSPKSQD HHHHHHHCCCCCCCC | 41.91 | 28450419 | |
355 | Phosphorylation | VRSLSSRSPKSQDSY HHHHHCCCCCCCCCC | 38.33 | 22115753 | |
357 | Ubiquitination | SLSSRSPKSQDSYPG HHHCCCCCCCCCCCC | 63.09 | 2190698 | |
358 | Phosphorylation | LSSRSPKSQDSYPGS HHCCCCCCCCCCCCC | 42.47 | 23927012 | |
361 | Phosphorylation | RSPKSQDSYPGSPSL CCCCCCCCCCCCCCC | 26.11 | 23927012 | |
362 | Phosphorylation | SPKSQDSYPGSPSLS CCCCCCCCCCCCCCC | 21.65 | 23401153 | |
365 | Phosphorylation | SQDSYPGSPSLSPRH CCCCCCCCCCCCCCC | 13.55 | 23927012 | |
367 | Phosphorylation | DSYPGSPSLSPRHGP CCCCCCCCCCCCCCC | 43.08 | 25159151 | |
369 | Phosphorylation | YPGSPSLSPRHGPSS CCCCCCCCCCCCCCC | 24.99 | 23927012 | |
375 | Phosphorylation | LSPRHGPSSSHMHNT CCCCCCCCCCCCCCC | 49.41 | 23927012 | |
376 | Phosphorylation | SPRHGPSSSHMHNTG CCCCCCCCCCCCCCC | 27.65 | 23927012 | |
377 | Phosphorylation | PRHGPSSSHMHNTGA CCCCCCCCCCCCCCC | 29.21 | 29496963 | |
382 | Phosphorylation | SSSHMHNTGADSPSC CCCCCCCCCCCCCCC | 21.04 | 23927012 | |
386 | Phosphorylation | MHNTGADSPSCSNGV CCCCCCCCCCCCCCC | 20.41 | 23927012 | |
388 | Phosphorylation | NTGADSPSCSNGVAS CCCCCCCCCCCCCCC | 33.84 | 23927012 | |
390 | Phosphorylation | GADSPSCSNGVASTK CCCCCCCCCCCCCCC | 40.74 | 23927012 | |
395 | Phosphorylation | SCSNGVASTKSKQNH CCCCCCCCCCCCCCC | 33.68 | 23927012 | |
396 | Phosphorylation | CSNGVASTKSKQNHS CCCCCCCCCCCCCCC | 29.60 | 23927012 | |
409 | Phosphorylation | HSKYPAPSSSSSSSS CCCCCCCCCCCCCCC | 44.98 | 23186163 | |
410 | Phosphorylation | SKYPAPSSSSSSSSS CCCCCCCCCCCCCCC | 32.93 | 23186163 | |
411 | Phosphorylation | KYPAPSSSSSSSSSS CCCCCCCCCCCCCCC | 38.28 | 23186163 | |
412 | Phosphorylation | YPAPSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
413 | Phosphorylation | PAPSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
414 | Phosphorylation | APSSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | 30576142 | |
415 | Phosphorylation | PSSSSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
416 | Phosphorylation | SSSSSSSSSSSSSSP CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
417 | Phosphorylation | SSSSSSSSSSSSSPS CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
418 | Phosphorylation | SSSSSSSSSSSSPSS CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
419 | Phosphorylation | SSSSSSSSSSSPSSV CCCCCCCCCCCCCCC | 35.87 | 23186163 | |
420 | Phosphorylation | SSSSSSSSSSPSSVN CCCCCCCCCCCCCCC | 36.46 | 23186163 | |
421 | Phosphorylation | SSSSSSSSSPSSVNY CCCCCCCCCCCCCCC | 48.49 | 23186163 | |
422 | Phosphorylation | SSSSSSSSPSSVNYS CCCCCCCCCCCCCCC | 30.65 | 23186163 | |
424 | Phosphorylation | SSSSSSPSSVNYSES CCCCCCCCCCCCCCC | 49.19 | 25262027 | |
425 | Phosphorylation | SSSSSPSSVNYSESN CCCCCCCCCCCCCCC | 20.12 | 25262027 | |
428 | Phosphorylation | SSPSSVNYSESNSTD CCCCCCCCCCCCCCC | 16.20 | 25262027 | |
429 | Phosphorylation | SPSSVNYSESNSTDS CCCCCCCCCCCCCCC | 29.37 | 24275569 | |
431 | Phosphorylation | SSVNYSESNSTDSTK CCCCCCCCCCCCCCC | 30.09 | - | |
434 | Phosphorylation | NYSESNSTDSTKSQH CCCCCCCCCCCCCCC | 37.91 | - | |
437 | Phosphorylation | ESNSTDSTKSQHHSS CCCCCCCCCCCCCCC | 37.21 | - | |
439 | Phosphorylation | NSTDSTKSQHHSSTS CCCCCCCCCCCCCCC | 34.53 | 23927012 | |
443 | Phosphorylation | STKSQHHSSTSNQET CCCCCCCCCCCCCCC | 32.94 | 23927012 | |
444 | Phosphorylation | TKSQHHSSTSNQETS CCCCCCCCCCCCCCC | 31.34 | 23927012 | |
445 | Phosphorylation | KSQHHSSTSNQETSD CCCCCCCCCCCCCCH | 34.41 | 23927012 | |
446 | Phosphorylation | SQHHSSTSNQETSDS CCCCCCCCCCCCCHH | 38.16 | 23927012 | |
450 | Phosphorylation | SSTSNQETSDSEMEM CCCCCCCCCHHHHHH | 28.24 | 23927012 | |
451 | Phosphorylation | STSNQETSDSEMEME CCCCCCCCHHHHHHH | 38.08 | 30576142 | |
453 | Phosphorylation | SNQETSDSEMEMEAE CCCCCCHHHHHHHHH | 38.31 | 30576142 | |
462 | Phosphorylation | MEMEAEHYPNGVLGS HHHHHHHCCCCHHHC | 7.01 | 30576142 | |
469 | Phosphorylation | YPNGVLGSMSTRIVN CCCCHHHCCHHEECC | 12.85 | 30576142 | |
471 | Phosphorylation | NGVLGSMSTRIVNGA CCHHHCCHHEECCCC | 19.07 | 27080861 | |
472 | Phosphorylation | GVLGSMSTRIVNGAY CHHHCCHHEECCCCC | 18.77 | 27080861 | |
480 | Ubiquitination | RIVNGAYKHEDLQTD EECCCCCCCCCCCCC | 39.73 | - | |
480 | Acetylation | RIVNGAYKHEDLQTD EECCCCCCCCCCCCC | 39.73 | 26051181 | |
486 | Phosphorylation | YKHEDLQTDESSMDD CCCCCCCCCCCCCCC | 49.37 | 23927012 | |
489 | Phosphorylation | EDLQTDESSMDDRHP CCCCCCCCCCCCCCH | 33.50 | 23927012 | |
490 | Phosphorylation | DLQTDESSMDDRHPR CCCCCCCCCCCCCHH | 24.96 | 23927012 | |
494 | Methylation | DESSMDDRHPRRQLC CCCCCCCCCHHHHHC | 37.13 | 115490235 | |
522 | Phosphorylation | GRELQALSEQLGREY HHHHHHHHHHHHHHH | 26.72 | 23898821 | |
529 | Phosphorylation | SEQLGREYGKNLAHT HHHHHHHHHHCHHHH | 31.85 | 23898821 | |
536 | Phosphorylation | YGKNLAHTEMLQDAF HHHCHHHHHHHHHHH | 19.92 | 26552605 | |
544 | Phosphorylation | EMLQDAFSLLAYSDP HHHHHHHHHHHHCCC | 24.97 | 26552605 | |
548 | Phosphorylation | DAFSLLAYSDPWSCP HHHHHHHHCCCCCCC | 17.36 | 26552605 | |
549 | Phosphorylation | AFSLLAYSDPWSCPV HHHHHHHCCCCCCCC | 31.43 | 26552605 | |
553 | Phosphorylation | LAYSDPWSCPVGQQL HHHCCCCCCCCCCCC | 17.58 | 26552605 | |
596 | Phosphorylation | MLALGQASECLRLMA CHHHHCHHHHHHHHH | 22.43 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RBP10_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBP10_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBP10_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RAN_HUMAN | RAN | physical | 14684163 | |
MET_HUMAN | MET | physical | 14684163 | |
WDR26_HUMAN | WDR26 | physical | 22939629 | |
WDR26_HUMAN | WDR26 | physical | 26344197 | |
ARMC8_HUMAN | ARMC8 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT TYR-362; SER-365 AND SER-369, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365 AND SER-369, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT TYR-362; SER-365 AND SER-369, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361; SER-365 ANDSER-369, AND MASS SPECTROMETRY. |